Oncology Clinical Trials in Palo Alto, CA

As of August 2026, 114 paid clinical trials are recruiting for Oncology in Palo Alto, California. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: August 31, 2026.

Filter results

State

City

Facility

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

116 clinical trials for Oncology

·Clear filters·

Email me when a new oncology trial opens in Palo Alto, CA.

Trial for Patients w/ Advanced Hematologic Malignancies Undergoing Allogeneic HCT

for Acute Myeloid Leukemia

1 location in Palo Alto

Sponsor: Stanford University

Sex: All·Age: 18 - 70

Code: NCT06551584·Phase 1·Recruiting·Listed Aug 2024

Apply to this trial

Treatment of Newly Diagnosed Rhabdomyosarcoma Using Molecular Risk Stratification and Liposomal Irinotecan Based Therapy in Children With Intermediate and High Risk Disease

for Rhabdomyosarcoma

Drug: Irinotecan

Sites in Palo Alto +2 more locations

Sponsor: St. Jude Children's Research Hospital

Sex: All·Age: Up to 22

Code: NCT06023641·Phase 2·Recruiting·Listed Sep 2023

Apply to this trial

5-Day Preoperative Radiation for Soft Tissue Sarcoma

for Soft Tissue Sarcoma

1 location in Palo Alto

Sponsor: Stanford University

Sex: All·Age: 18+

Code: NCT06087861·Phase 2·Recruiting·Listed Oct 2023

Apply to this trial

Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients

for Non Small Cell Lung Cancer

Drug: Osimertinib

Sites in Palo Alto, San Jose +144 more locations

Sponsor: PrECOG, LLC.

Sex: All·Age: 18+

Code: NCT06538038·Recruiting·Listed Aug 2024

Apply to this trial

Trial of Relatlimab, Nivolumab, and Ipilimumab in Patients With Asymptomatic and Symptomatic Melanoma Brain Metastases

for Melanoma

Drug: Ipilimumab

1 location in Palo Alto

Sponsor: Stanford University

Sex: All·Age: 18+

Code: NCT06712927·Phase 2·Recruiting·Listed Dec 2024

Apply to this trial

Autologous B7-H3 Chimeric Antigen Receptor T Cells in Relapsed/Refractory Solid Tumors

for Neuroblastoma

1 location in Palo Alto

Sponsor: Stanford University

Sex: All·Age: 2 - 30

Code: NCT06500819·Phase 1·Recruiting·Listed Jul 2024

Apply to this trial

REGULUS: MRI-guided Adaptive SABR for Liver Cancers

for Liver Cancer

1 location in Palo Alto

Sponsor: Stanford University

Sex: All·Age: 18+

Code: NCT07223307·Phase 2·Recruiting·Listed Oct 2025

Apply to this trial

Engagement of Veterans With Lung Cancer

for Lung Cancer (NSCLC)

1 location in Palo Alto

Sponsor: Palo Alto Veterans Institute for Research

Sex: All·Age: 18+

Code: NCT07219251·Recruiting·Listed Oct 2025

Apply to this trial

A Study of Selinexor in People With Wilms Tumors and Other Solid Tumors

for Wilms Tumor

Drug: Selinexor

Sites in Palo Alto, Los Angeles +14 more locations

Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All·Age: 12 Months+

Code: NCT05985161·Phase 2·Recruiting·Listed Aug 2023

Apply to this trial

Tagraxofusp and Low-Intensity Chemotherapy for CD123-Positive Relapsed or Refractory AML

for Refractory Acute Myeloid Leukemia

1 location in Palo Alto

Sponsor: Stanford University

Sex: All·Age: 18+

Code: NCT06561152·Phase 1, Phase 2·Recruiting·Listed Aug 2024

Apply to this trial

Personalized Accelerated ChEmoRadiation (PACER) for Lung Cancer

for Lung Cancer

Sites in Palo Alto & San Jose

Sponsor: Stanford University

Sex: All·Age: 18+

Code: NCT06080061·Phase 1·Recruiting·Listed Oct 2023

Apply to this trial

Digital Phenotyping for Psychosocial Screening in Adolescents and Young Adults With Cancer

for Cancer

1 location in Palo Alto

Sponsor: Stanford University

Sex: All·Age: 10 - 25

Code: NCT07220343·Recruiting·Listed Oct 2025

Apply to this trial

Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial

for Metastatic Clear Cell Renal Cell Carcinoma

Sites in Palo Alto, Sunnyvale +338 more locations

Sponsor: SWOG Cancer Research Network

Sex: All·Age: 18+

Code: NCT04510597·Phase 3·Recruiting·Listed Aug 2020

Apply to this trial

A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation

for AML (Acute Myelogenous Leukemia)

Sites in Palo Alto, Duarte +11 more locations

Sponsor: Center for International Blood and Marrow Transplant Research

Sex: All·Age: 18 - 66

Code: NCT06859424·Phase 2·Recruiting·Listed Mar 2025

Apply to this trial

Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery

for Pancreatic Adenocarcinoma

1 location in Palo Alto

Sponsor: George Poultsides

Sex: All·Age: 19+

Code: NCT03384238·Phase 1, Phase 2·Recruiting·Listed Dec 2017

Apply to this trial

Acalabrutinib, Venetoclax and Durvalumab for the Treatment of Richter Transformation From Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

for Chronic Lymphocytic Leukemia

Drug: Durvalumab

Sites in Palo Alto +1 more location

Sponsor: Mayo Clinic

Sex: All·Age: 18+

Code: NCT05388006·Phase 2·Recruiting·Listed May 2022

Apply to this trial

Panitumumab-IRDye800 in Detecting Cancer in Participants With Lung Cancer During Surgery

for Lung Carcinoma

1 location in Palo Alto

Sponsor: Stanford University

Sex: All·Age: 19+

Code: NCT03582124·Phase 1, Phase 2·Recruiting·Listed Jul 2018

Apply to this trial

Pediatric PET/MR Image Registry

for Soft Tissue

1 location in Palo Alto

Sponsor: Stanford University

Sex: All·Age: Up to 40

Code: NCT03458520·Recruiting·Listed Mar 2018

Apply to this trial

Molecular and Cellular Profiling of Uterine Lavage Collected During Gynecologic Surgery

for Gynecologic Cancer

1 location in Palo Alto

Sponsor: Stanford University

Sex: All·Age: 18+

Code: NCT07044505·Recruiting·Listed Jul 2025

Apply to this trial

Autologous CD22 CAR T Cells Following Commercial CD19 CAR T Cells in B Cell Malignancies

for Leukemia

1 location in Palo Alto

Sponsor: Stanford University

Sex: All·Age: 1 - 25

Code: NCT06408194·Phase 1·Recruiting·Listed May 2024

Apply to this trial

Evaluate Safety of Axicabtagene Ciloleucel Reinfusion (Axi-Cel-2) in Patients With Relapsed and/or Refractory Second Line High-Risk Non-Hodgkin Lymphoma After Standard of Care Axi-Cel

for Non-Hodgkin Lymphoma

1 location in Palo Alto

Sponsor: Stanford University

Sex: All·Age: 18+

Code: NCT05794958·Phase 1·Recruiting·Listed Apr 2023

Apply to this trial

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

for Hodgkin Lymphoma in Remission

Sites in Palo Alto, Oakland +54 more locations

Sponsor: Children's Oncology Group

Sex: All·Age: All ages

Code: NCT01790152·Recruiting·Listed Feb 2013

Apply to this trial

A Phase II Trial to Evaluate the Effect of Itraconazole on Pathologic Complete Response Rates in Resectable Esophageal Cancer

for Esophageal Adenocarcinoma

Sites in Palo Alto +6 more locations

Sponsor: VA Office of Research and Development

Sex: All·Age: 18+

Code: NCT05563766·Phase 2·Recruiting·Listed Oct 2022

Apply to this trial

Clinical Trial of Autologous B7-H3 CAR T Cells in Reoccurent Platinum-resistant Ovarian Tumors

for Ovarian Cancer

1 location in Palo Alto

Sponsor: Stanford University

Sex: Female·Age: 18+

Code: NCT06646627·Phase 1·Recruiting·Listed Oct 2024

Apply to this trial

Neratinib and Fam-Trastuzumab Deruxtecan in Advanced Gastro-esophageal Cancer Patients

for Gastric Cancer

Sites in Palo Alto +2 more locations

Sponsor: Fox Chase Cancer Center

Sex: All·Age: 18+

Code: NCT05274048·Phase 1·Recruiting·Listed Mar 2022

Apply to this trial

Study of QUAIL-100 in Pediatric and Young Adult Participants With High-Risk Hematologic Malignancies Who Have Received a Hematopoietic Stem Cell Transplantation

for Acute Leukemia

1 location in Palo Alto

Sponsor: Laguna Biotherapeutics, Inc.

Sex: All·Age: 18 Months - 39

Code: NCT07573111·Phase 1·Recruiting·Listed May 2026

Apply to this trial

TACrolimus Targeted Immunosuppression Cessation in ALlogeneic HCT

for GVHD

1 location in Palo Alto

Sponsor: Stanford University

Sex: All·Age: 18 - 80

Code: NCT07302776·Phase 1·Recruiting·Listed Dec 2025

Apply to this trial

A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)

for Biliary Tract Cancer

Drug: Rilvegostomig

Sites in Palo Alto, Los Angeles +34 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT07221253·Phase 3·Recruiting·Listed Oct 2025

Apply to this trial

AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2

for Gastric Cancer

Sites in Palo Alto, Santa Rosa +5 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT06219941·Phase 2·Recruiting·Listed Jan 2024

Apply to this trial

Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma

for Hepatocellular Carcinoma

Drug: Rilvegostomig

Sites in Palo Alto, Los Angeles +29 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT06921785·Phase 3·Recruiting·Listed Apr 2025

Apply to this trial

A Phase 3 Study to Evaluate Petosemtamab Compared With Investigator's Choice Monotherapy in Previously Treated Head and Neck Squamous Cell Carcinoma Patients (LiGeR-HN2)

for Head and Neck Squamous Cell Carcinoma

Drug: Petosemtamab

Sites in Palo Alto, San Francisco +59 more locations

Sponsor: Merus B.V.

Sex: All·Age: 18+

Code: NCT06496178·Phase 3·Recruiting·Listed Jul 2024

Apply to this trial

A Phase 3 Study to Evaluate Petosemtamab Plus Pembrolizumab vs Pembrolizumab in First-line Treatment of Head and Neck Cancer (LiGeR - HN1)

for Head and Neck Squamous Cell Carcinoma

Drug: Petosemtamab

Sites in Palo Alto, Los Angeles +34 more locations

Sponsor: Merus B.V.

Sex: All·Age: 18+

Code: NCT06525220·Phase 3·Recruiting·Listed Jul 2024

Apply to this trial

A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate Cancer

for Metastatic Castration-Resistant Prostate Cancer

Sites in Palo Alto, San Diego +10 more locations

Sponsor: AstraZeneca

Sex: Male·Age: 18+

Code: NCT06879041·Phase 1·Recruiting·Listed Mar 2025

Apply to this trial

A Phase 1/2 Study of BHV-1510 (Previously PBI-410) in Advanced Solid Tumors

for Solid Tumor

Sites in Palo Alto, Duarte +15 more locations

Sponsor: Biohaven Therapeutics Ltd.

Sex: All·Age: 18+

Code: NCT06384807·Phase 1, Phase 2·Recruiting·Listed Apr 2024

Apply to this trial

Conditions in Oncology (Palo Alto, CA)

Solid tumor· 17 Cancer (any)· 13 Breast cancer· 10 Non-small cell lung cancer (NSCLC)· 9 Acute myeloid leukemia (AML)· 8 Myelodysplastic syndromes (MDS)· 8 Ovarian cancer· 7 Chronic lymphocytic leukemia (CLL)· 7 Non-Hodgkin lymphoma· 7 Leukemia (other)· 6 Small lymphocytic lymphoma· 6 Osteosarcoma· 6 Colorectal cancer· 5 Pancreatic cancer· 5 Metastatic prostate cancer· 5 Prostate cancer· 4 Diffuse large B-cell lymphoma (DLBCL)· 4 Metastatic breast cancer· 3 Lung cancer· 3 Gastric cancer· 3 Liver cancer· 3 Biliary tract cancer· 3 Endometrial cancer· 3 Multiple myeloma· 3 Acute lymphoblastic leukemia· 3 Follicular lymphoma· 3 Mantle cell lymphoma· 3 Head and neck cancer· 3 Neuroblastoma· 3 Kidney cancer· 2 Fallopian tube cancer· 2 Glioma· 2 Myeloproliferative neoplasm· 2 Marginal zone lymphoma· 2 Melanoma· 2 Triple-negative breast cancer· 1 Esophageal cancer· 1 Gastroesophageal junction cancer· 1 Gastrointestinal cancer· 1 Bladder cancer· 1 Cervical cancer· 1 Uterine cancer· 1 Gynecologic cancer· 1 Brain cancer· 1 Brain metastases· 1 Chronic myelomonocytic leukemia· 1 Myelofibrosis· 1 Hodgkin lymphoma· 1 Burkitt lymphoma· 1 Hematologic malignancy· 1 Sarcoma· 1 Soft tissue sarcoma· 1 Ewing sarcoma· 1 Rhabdomyosarcoma· 1 Mesothelioma· 1 Neuroendocrine tumors· 1